Related Experiment Video
Updated: Aug 9, 2026
08:58
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Pulmonary inflammation and bronchopulmonary dysplasia
1Department of Pediatrics, University Children's Hospital, Würzburg, Germany. speer_c@klinik.uni-wuerzburg.de
Summary
Bronchopulmonary dysplasia in preterm infants involves harmful inflammation and an imbalance of protective factors. Understanding these inflammatory pathways is crucial for improving lung development and treatment strategies.
Area of Science:
- Neonatal Medicine
- Pulmonary Medicine
- Inflammation Research
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting preterm infants.
- Pre- and postnatal risk factors contribute to inflammatory responses in the lungs.
- This inflammation impacts airway and pulmonary interstitium integrity.
Purpose of the Study:
- To summarize current concepts on the role of inflammation in BPD pathogenesis.
- To review the inflammatory mediators and cellular players involved in BPD.
- To discuss the imbalance of pro- and anti-inflammatory factors in BPD.
Main Methods:
- Review of existing literature on inflammation and BPD.
- Analysis of the cellular and molecular mechanisms of lung injury in BPD.
- Synthesis of current understanding of inflammatory pathways in BPD.
Main Results:
- Inflammatory response characterized by neutrophils, macrophages, and mediators.
- Proinflammatory cytokines, oxygen radicals, lipid mediators, and proteases contribute to lung injury.
- Imbalance between pro- and anti-inflammatory factors is a key feature.
- Subnormal growth factor generation may impair alveolarization and vascular development.
Conclusions:
- Inflammation plays a critical role in the pathogenesis of bronchopulmonary dysplasia.
- Aberrant inflammatory responses and mediator imbalances are central to BPD development.
- Further research into anti-inflammatory strategies is warranted for BPD treatment.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...